Flow cytometry and the future of vaccine development

Expert Review of Vaccines

Volumn 8, Issue 6, 2009, Pages 779-789

  Bolton, Diane L ^a   Roederer, Mario ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antigen specific immune response; Multiparameter flow cytometry; Polyfunctional T cell; Vaccine

Indexed keywords

ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNE RESPONSE; INNATE IMMUNITY; MALARIA; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUBERCULOSIS;

ANTIGENS, SURFACE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE SUBSETS; VACCINES;

EID: 67049142938     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.09.41     Document Type: Review

References (76)

1. Chattopadhyay PK, Hogerkorp CM, Roederer M. A chromatic explosion: the development and future of multiparameter flow cytometry. Immunology 125(4), 441-449 (2008).
2. Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65(1-2), 109-121 (1983). (Pubitemid 14203438)
3. De Rosa SC, Lu FX, Yu J et al. Vaccination in humans generates broad T-cell cytokine responses. J. Immunol. 173(9), 5372-5380 (2004). (Pubitemid 39392120)
4. Darrah PA, Patel DT, De Luca PM et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13(7), 843-850 (2007). •• First prospective evidence that vaccine-induced Th1 cells secreting multiple cytokines simultaneously correlate with protection against disease. (Pubitemid 47038186)
5. + T-cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281(1-2), 65-78 (2003).
6. + T-cells with diverse cytokine profiles. Nat. Med. 11(10), 1113-1117 (2005).
7. + T-cell responses to smallpox and yellow fever vaccines. Immunity 28(5), 710-722 (2008).
8. + T-cells confer superior antitumor immunity compared with effector memory T-cells. Proc. Natl Acad. Sci. USA 102(27), 9571-9576 (2005).
9. Roberts AD, Ely KH, Woodland DL. Differential contributions of central and effector memory T-cells to recall responses. J. Exp. Med. 202(1), 123-133 (2005). (Pubitemid 41002915)
10. Wherry EJ, Teichgraber V, Becker TC et al. Lineage relationship and protective immunity of memory CD8 T-cell subsets. Nat. Immunol. 4(3), 225-234 (2003). (Pubitemid 36322131)
11. Palmowski M, Salio M, Dunbar RP, Cerundolo V. The use of HLA class I tetramers to design a vaccination strategy for melanoma patients. Immunol. Rev. 188, 155-163 (2002). (Pubitemid 35398873)
12. Vollers SS, Stern LJ. Class II major histocompatibility complex tetramer staining: progress, problems, and prospects. Immunology 123(3), 305-313 (2008).
13. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401(6754), 708-712 (1999). (Pubitemid 129515761)
14. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8(4), 247-258 (2008).
15. Hansen SG, Vieville C, Whizin N et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15(3), 293-299 (2009).
16. Harari A, Petitpierre S, Vallelian F, Pantaleo G. Skewed representation of functionally distinct populations of virus-specific CD4 T-cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103(3), 966-972 (2004). (Pubitemid 38129558)
17. + T-cells. Blood 107(12), 4781-4789 (2006).
18. Duvall MG, Precopio ML, Ambrozak DA et al. Polyfunctional T-cell responses are a hallmark of HIV-2 infection. Eur. J. Immunol. 38(2), 350-363 (2008).
19. Forbes EK, Sander C, Ronan EO et al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J. Immunol. 181(7), 4955-4964 (2008).
20. Shulman N, Bellew M, Snelling G et al. Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials. Cytometry A 73(9), 847-856 (2008).
21. Chen R, Lowe L, Wilson JD et al. Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology. Clin. Chem. 45(9), 1693-1694 (1999). • Development of a flow cytometric multiplex bead array to detect up to six human cytokines from a single sample simultaneously. Applications extend to measuring multiple antibodies or other soluble factors from serum or tissue secretions.
22. Elshal MF, McCoy JP. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 38(4), 317-323 (2006).
23. Garcia-Pineres A, Hildesheim A, Dodd L et al. Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 virus-like particles. Clin. Vaccine Immunol. 14(8), 984-989 (2007).
24. Pinto LA, Castle PE, Roden RB et al. HPV-16 L1 VLP vaccine elicits a broadspectrum of cytokine responses in whole blood. Vaccine 23(27), 3555-3564 (2005). (Pubitemid 40602790)
25. Morgan E, Varro R, Sepulveda H et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 110(3), 252-266 (2004). (Pubitemid 38402005)
26. Pei R, Lee J, Chen T, Rojo S, Terasaki PI. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum. Immunol. 60(12), 1293-1302 (1999). (Pubitemid 30017514)
27. Pierangeli SS, Silva LK, Harris EN. A flow cytometric assay for the detection of antiphospholipid antibodies. Am. Clin. Lab. 18(6), 18-19 (1999).
28. + T-cells specific for defined antigens according to CD154 expression. Nat. Med. 11(10), 1118-1124 (2005).
29. Harcourt JL, Brown MP, Anderson LJ, Tripp RA. CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice. Vaccine 21(21-22), 2964-2979 (2003). (Pubitemid 36705535)
30. Horton H, Frank I, Baydo R et al. Preservation of T-cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J. Immunol. 177(10), 7406-7415 (2006). (Pubitemid 44715111)
31. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243(1-2), 147-154 (2000).
32. Wallace PK, Tario JD Jr, Fisher JL, Wallace SS, Ernstoff MS, Muirhead KA. Tracking antigen-driven responses by flow cytometry: monitoring proliferation by dye dilution. Cytometry A 73(11), 1019-1034 (2008). •• Thoroughly reviews the technical aspects of working with proliferation dyes, including compatibility with other reagents, the limitations and advantages of using membrane versus protein-labeling dyes, data analysis and validation.
33. + T-cells capable of antigen-specific expansion and effector functions. J. Infect. Dis. 192(8), 1362-1371 (2005).
34. + T-cells after the injection of tumor cells expressing IFN-a1 into syngeneic mice. Cancer Res. 58(24), 5795-5802 (1998).
35. Picker LJ, Reed-Inderbitzin EF, Hagen SI et al. IL-15 induces CD4 effector memory T-cell production and tissue emigration in nonhuman primates. J. Clin. Invest. 116(6), 1514-1524 (2006). (Pubitemid 43911006)
36. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle ana lysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133(4), 1710-1715 (1984). (Pubitemid 14035254)
37. + T lymphocytes produce multiple cytokines and proliferate in vivo in humans. J. Immunol. 177(11), 8185-8190 (2006).
38. + T-cells following re-immunization. Eur. J. Immunol. 37(4), 1129-1138 (2007).
39. Godoy-Ramirez K, Makitalo B, Thorstensson R, Sandstrom E, Biberfeld G, Gaines H. A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry. Cytometry A 68(2), 71-80 (2005). (Pubitemid 41705200)
40. Sheehy ME, McDermott AB, Furlan SN, Klenerman P, Nixon DF. A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J. Immunol. Methods 249(1-2), 99-110 (2001). (Pubitemid 32171963)
41. Liu L, Chahroudi A, Silvestri G et al. Visualization and quantification of T-cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat. Med. 8(2), 185-189 (2002). (Pubitemid 34155131)
42. Ritchie DS, Hermans IF, Lumsden JM et al. Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo. J. Immunol. Methods 246(1-2), 109-117 (2000).
43. Rubio V, Stuge TB, Singh N et al. Ex vivo identification, isolation and ana lysis of tumor-cytolytic T-cells. Nat. Med. 9(11), 1377-1382 (2003). (Pubitemid 37466186)
44. + T-cells store RANTES in a unique secretory compartment and release it rapidly after TCR stimulation. Immunity 20(2), 219-230 (2004).
45. Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr. Infect. Dis. J. 20(1), 63-75 (2001). (Pubitemid 32066180)
46. Aase A, Hoiby EA, Michaelsen TE. Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine. Scand. J. Immunol. 47(4), 388-396 (1998). (Pubitemid 28206436)
47. Martinez JE, Romero-Steiner S, Pilishvili T et al. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin. Diagn. Lab. Immunol. 6(4), 581-586 (1999). (Pubitemid 29330747)
48. Martinez JE, Clutterbuck EA, Li H, Romero-Steiner S, Carlone GM. Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae. Clin. Vaccine Immunol. 13(4), 459-466 (2006). • Demonstrates that functional, opsonic antibodies against multiple pneumococci serotypes can be measured simultaneously in human vaccinee sera. (Pubitemid 44044831)
49. Aase A, Michaelsen TE. Opsonophagocytic activity induced by chimeric antibodies of the four human IgG subclasses with or without help from complement. Scand. J. Immunol. 39(6), 581-587 (1994). (Pubitemid 24217151)
50. Findlow J, Taylor S, Aase A et al. Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac. Infect. Immun. 74(8), 4557-4565 (2006). (Pubitemid 44157242)
51. Alsmadi O, Herz R, Murphy E, Pinter A, Tilley SA. A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection. J. Virol. 71(2), 925-933 (1997). (Pubitemid 27030262)
52. Gomez-Roman VR, Florese RH, Patterson LJ et al. A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. J. Immunol. Methods 308(1-2), 53-67 (2006). (Pubitemid 43107954)
53. Guyre CA, Gomes D, Smith KA, Kaplan JM, Perricone MA. Development of an in vivo antibody-mediated killing (IVAK) model, a flow cytometric method to rapidly evaluate therapeutic antibodies. J. Immunol. Methods 333(1-2), 51-60 (2008).
54. Ragupathi G, Liu NX, Musselli C, Powell S, Lloyd K, Livingston PO. Antibodies against tumor cell glycolipids and proteins, but not mucins, mediate complement-dependent cytotoxicity. J. Immunol. 174(9), 5706-5712 (2005). (Pubitemid 40593213)
55. Jaskowski TD, Martins TB, Litwin CM, Hill HR. Comparison of three different methods for measuring classical pathway complement activity. Clin. Diagn. Lab. Immunol. 6(1), 137-139 (1999). (Pubitemid 29035654)
56. Diaz TM, Pertega S, Ortega D et al. FDA/PI flow cytometry assay of complement-mediated cytotoxicity of antibodies generated during xenotransplantation. Cytometry A 62(1), 54-60 (2004). (Pubitemid 39473453)
57. Sedgwick JD, Holt PG. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 57(1-3), 301-309 (1983).
58. Julius MH, Masuda T, Herzenberg LA. Demonstration that antigen-binding cells are precursors of antibody-producing cells after purification with a fluorescence-activated cell sorter. Proc. Natl Acad. Sci. USA 69(7), 1934-1938 (1972).
59. Leyendeckers H, Odendahl M, Lohndorf A et al. Correlation ana lysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur. J. Immunol. 29(4), 1406-1417 (1999). (Pubitemid 29164188)
60. Moody MA, Haynes BF. Antigen-specific B cell detection reagents: use and quality control. Cytometry A 73(11), 1086-1092 (2008).
61. Townsend SE, Goodnow CC, Cornall RJ. Single epitope multiple staining to detect ultralow frequency B cells. J. Immunol. Methods 249(1-2), 137-146 (2001). (Pubitemid 32171966)
62. Amanna IJ, Slifka MK. Quantitation of rare memory B cell populations by two independent and complementary approaches. J. Immunol. Methods 317(1-2), 175-185 (2006). • Development of a flow cytometric assay to enumerate antigen-specific memory B cells in human clinical samples using a dual antigen-staining approach with mismatched fluorescent labels to improve specificity. (Pubitemid 44809205)
63. Newman J, Rice JS, Wang C, Harris SL, Diamond B. Identification of an antigen-specific B cell population. J. Immunol. Methods 272(1-2), 177-187 (2003). (Pubitemid 36050754)
64. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357(19), 1903-1915 (2007). (Pubitemid 350074686)
65. Doucett VP, Gerhard W, Owler K, Curry D, Brown L, Baumgarth N. Enumeration and characterization of virus-specific B cells by multicolor flow cytometry. J. Immunol. Methods 303(1-2), 40-52 (2005). (Pubitemid 41169944)
66. Tiller T, Meffre E, Yurasov S, Tsuiji M, Nussenzweig MC, Wardemann H. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329(1-2), 112-124 (2008). •• Technological advance in which antibodies are cloned from single sorted antigen-specific B-cell populations, enabling immunoglobulin gene sequencing and recombinant antibody expression. (Pubitemid 350235462)
67. Gerosa F, Gobbi A, Zorzi P et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 174(2), 727-734 (2005). (Pubitemid 40094266)
68. Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19(2), 225-234 (2003). (Pubitemid 37011337)
69. Lore K, Betts MR, Brenchley JM et al. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T-cell responses. J. Immunol. 171(8), 4320-4328 (2003). • Demonstration that Toll-like receptor agonists have different effects on dendritic cell activation and the ability of dendritic cells to stimulate T cells. (Pubitemid 37238711)
70. + T-cell-stimulating skin-emigrated dendritic cells. J. Immunol. 177(4), 2208-2215 (2006).
71. Lore K, Adams WC, Havenga MJ et al. Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T-cell responses. J. Immunol. 179(3), 1721-1729 (2007).
72. Liu L, Chavan R, Feinberg MB. Dendritic cells are preferentially targeted among hematolymphocytes by modified vaccinia virus Ankara and play a key role in the induction of virus-specific T-cell responses in vivo. BMC Immunol. 9, 15 (2008).
73. Zimmerman ES, Sherman MP, Blackett JL et al. Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. J. Virol. 80(21), 10407-10418 (2006). (Pubitemid 44628888)
74. Horton H, Thomas EP, Stucky JA et al. Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T-cells induced by vaccination. J. Immunol. Methods 323(1), 39-54 (2007). (Pubitemid 46722712)
75. Rosette C, Werlen G, Daniels MA et al. The impact of duration versus extent of TCR occupancy on T-cell activation: a revision of the kinetic proofreading model. Immunity 15(1), 59-70 (2001). (Pubitemid 32728320)
76. Perez OD, Nolan GP. Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunol. Rev. 210, 208-228 (2006).